Results 111 to 120 of about 21,587 (248)

HEPATORENAL SYNDROME: A REVIEW [PDF]

open access: yesArchives of the Balkan Medical Union, 2018
Hepatorenal syndrome (HRS) is defined as a functional renal failure in patients with liver disease that features morphologically intact kidneys, where regulatory mechanisms have minimized glomerular filtration and maximized tubular resorption and urine ...
Diana DIACONESCU   +8 more
doaj  

Updated Reference Limits for Liver Blood Tests With Validation Against Long‐Term Liver‐Related Outcomes

open access: yesLiver International, Volume 45, Issue 12, December 2025.
ABSTRACT Background and Aims Liver blood tests are widely used, but their reference limits may not reliably predict long‐term liver‐related risks. Previous studies to establish reference limits often lacked rigorous exclusion of individuals with undiagnosed liver disease or associated risk factors.
Fredrik Åberg   +6 more
wiley   +1 more source

COMPARISON OF EFFICACY ON NORADRENALINE AND TERLIPRESSIN IN HEPATORENAL SYNDROME IN THE PATIENTS OF DECOMPENSATED CIRRHOSIS – A RANDOMIZED CONTROLLED STUDY

open access: yesPakistan Armed Forces Medical Journal, 2019
Objective: To compare the efficacy of noradrenaline and terlipressin in hepatorenal syndrome. Study Design: Randomized controlled trial. Place and Duration of Study: Combined Military Hospital Lahore, from May 2018 to Jan 2019.
Muhammad Siddique   +2 more
doaj  

A STUDY OF HYPONATREMIA IN PATIENTS OF LIVER CIRRHOSIS IN A TERTIARY CARE HOSPITAL OF SOUTH GUJARAT

open access: yesNational Journal of Medical Research, 2021
Introduction: Hyponatremia is the most common electrolyte abnormality in patients with liver cirrhosis and associates with the poor prognosis and the complications like hepatorenal syndrome, ascites etc.
Urvi B Patel   +2 more
doaj  

GLP‐1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score Matching

open access: yesLiver International, Volume 45, Issue 12, December 2025.
ABSTRACT Background and Aims GLP‐1 receptor agonists (GLP‐1RA) are widely used in type 2 diabetes mellitus (T2DM) and may confer hepatoprotective effects in metabolic dysfunction‐associated steatotic liver disease (MASLD). Their impact on liver fibrosis progression in real‐world clinical settings remains unclear.
Jonggi Choi   +9 more
wiley   +1 more source

Diagnostic and prognostic value of Doppler ultrasound study in hepatorenal syndrome. A report of a case

open access: yesActa Médica del Centro, 2016
Hepatorenal syndrome is a condition that occurs in patients with chronic liver disease characterized by portal hypertension and it is distinguished by the deterioration of renal function and marked abnormalities in blood circulation, with activation of ...
Raysa Garay Padrón   +2 more
doaj  

Emergency Abdominal Surgery in Patient with Liver Cirrhosis [PDF]

open access: yes, 2007
The number of patients with cirrhosis who require surgery is increasing. Therefore, it can be expected that a growing number of patients with cirrhosis will undergo surgery.
Cahyono, J. S. (JB)
core  

Hepatorenal Syndrome with Cirrhotic Cardiomyopathy: Case Report and Literature Review [PDF]

open access: gold, 2015
Luís Otávio Mocarzel   +5 more
openalex   +1 more source

Analysis of Risk Factors for Patients with Liver Cirrhosis Complicated with Spontaneous Bacterial Peritonitis

open access: yesIranian Journal of Public Health, 2018
Background: We aimed to explore risk factors for patients with liver cirrhosis complicated with spontaneous bacterial peritonitis (SBP). Methods: The clinical data of 195 patients with liver cirrhosis complicated with SBP (study group), admitted from ...
Yuan WANG, Qingyu ZHANG
doaj  

A comparative analysis between Model for End-stage Liver Disease score (MELD), Modified Model for End-stage Liver Disease score (MELD-Na), and Child–Pugh score (CPS) in predicting complications among cirrhosis patients

open access: yesThe Egyptian Journal of Internal Medicine
Aim This study aims to compare the effectiveness of the model for end-stage liver disease (MELD), the modified model for end-stage liver disease including sodium (MELD-Na), and the Child–Pugh score (CPS) in predicting complications in patients with ...
Anagha Ravinath Naik, Swathy Moorthy
doaj   +1 more source

Home - About - Disclaimer - Privacy